Similar articles for PMID: 14638658

Year	Number of Results
2003	1
2004	10
2005	13
2006	5
2007	5
2008	4
2009	5
2024	0

1

Does the choice of beta-blocker affect outcome in chronic heart failure?

Bal SK. Bal SK. CMAJ. 2003 Nov 25;169(11):1188. CMAJ. 2003. PMID: 14638658 Free PMC article. No abstract available.

2

[Elderly heart failure patients and the role of beta-blocker therapy].

Middeljans-Tijssen CW, Jansen RW. Middeljans-Tijssen CW, et al. Tijdschr Gerontol Geriatr. 2006 Apr;37(2):67-77. Tijdschr Gerontol Geriatr. 2006. PMID: 16704019 Review. Dutch.

3

Why do patients fail to receive beta-blockers for chronic heart failure over time? A "real-world" single-center, 2-year follow-up experience of beta-blocker therapy in patients with chronic heart failure.

Parameswaran AC, Tang WH, Francis GS, Gupta R, Young JB. Parameswaran AC, et al. Am Heart J. 2005 May;149(5):921-6. doi: 10.1016/j.ahj.2004.07.026. Am Heart J. 2005. PMID: 15894978

4

Beta-blocker therapy in heart failure in the elderly.

Fu M. Fu M. Int J Cardiol. 2008 Apr 10;125(2):149-53. doi: 10.1016/j.ijcard.2007.10.010. Epub 2007 Nov 19. Int J Cardiol. 2008. PMID: 18023898 Review.

5

What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).

Gullestad L, Wikstrand J, Deedwania P, Hjalmarson A, Egstrup K, Elkayam U, Gottlieb S, Rashkow A, Wedel H, Bermann G, Kjekshus J; MERIT-HF Study Group. Gullestad L, et al. J Am Coll Cardiol. 2005 Jan 18;45(2):252-9. doi: 10.1016/j.jacc.2004.10.032. J Am Coll Cardiol. 2005. PMID: 15653024 Free article. Clinical Trial.

6

Age is not a significant risk factor for failed trial of beta-blocker therapy in older patients with chronic heart failure.

Witham MD, Gillespie ND, Struthers AD. Witham MD, et al. Age Ageing. 2004 Sep;33(5):467-72. doi: 10.1093/ageing/afh150. Epub 2004 Jun 24. Age Ageing. 2004. PMID: 15217777

7

Nonselective versus selective beta-blockers in the management of chronic heart failure: clinical implications of the carvedilol or Metoprolol European Trial.

Greenberg B. Greenberg B. Rev Cardiovasc Med. 2004;5 Suppl 1:S10-7. Rev Cardiovasc Med. 2004. PMID: 15184835 Review.

8

Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study.

Jost A, Rauch B, Hochadel M, Winkler R, Schneider S, Jacobs M, Kilkowski C, Kilkowski A, Lorenz H, Muth K, Zugck C, Remppis A, Haass M, Senges J; HELUMA study group. Jost A, et al. Eur Heart J. 2005 Dec;26(24):2689-97. doi: 10.1093/eurheartj/ehi473. Epub 2005 Sep 23. Eur Heart J. 2005. PMID: 16183697

9

Pharmacological treatment of chronic heart failure according to the 2005 guidelines of the European Society of Cardiology.

Voors AA, van Veldhuisen DJ. Voors AA, et al. Minerva Cardioangiol. 2005 Aug;53(4):233-9. Minerva Cardioangiol. 2005. PMID: 16177668 Review. English, Italian.

10

Restoration of heart rate turbulence by titrated beta-blocker therapy in patients with advanced congestive heart failure: positive correlation with enhanced vagal modulation of heart rate.

Lin LY, Hwang JJ, Lai LP, Chan HL, Du CC, Tseng YZ, Lin JL. Lin LY, et al. J Cardiovasc Electrophysiol. 2004 Jul;15(7):752-6. doi: 10.1046/j.1540-8167.2004.03289.x. J Cardiovasc Electrophysiol. 2004. PMID: 15250856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

40 results

Results by year